Le Lézard
Classified in: Health
Subject: RCL

Salud Natural Entrepreneur Inc. Recalls Nopalina Flax Seed Fiber Powder and Nopalina Flax Seed Fiber Capsules Because of Possible Health Risk


WAUKEGAN, Ill., Jan. 29, 2020 /PRNewswire/ -- Salud Natural Entrepreneur, Inc. of Waukegan, IL is voluntarily recalling Nopalina Flax Seed Fiber (powder) and Nopalina Flax Seed Fiber (capsule) products due to possible Salmonella contamination in one of the ingredients used on the formula of Nopalina Flax Seed Fiber. Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis. Consumers of these products who are experiencing symptoms of Salmonella should contact their health care provider. To date, there are no reports of illnesses associated with the products.

Nopalina Flax Seed products are distributed throughout the United States and Puerto Rico via retail stores and the company's web site https://www.nopalinaonline.com/ 

The following lot numbers are affected by this recall (the lot numbers can be found on the bottom back of the product label):

Nopalina Flax Seed Fiber (powder, 2 lb. bags)  UPC:890523000843

Nopalina Flax Seed Fiber (capsules, 120 count)   UPC 890523000867

This recall is being made with the knowledge of the Food and Drug Administration.

The recall is the result of an FDA sampling of senna leaves powder, an ingredient used to manufacture the Nopalina Flax Seed Fiber (powder) and Nopalina Flax Seed Fiber (capsules), that tested positive for three types of Salmonella including Salmonella Gaminara, Salmonella Kentucky, and Salmonella Oranienburg. The company has ceased the use of the suspect ingredient.

We care deeply about the health of all of our consumers and are committed to providing with safe and high quality products. Salud Natural Entrepreneur, Inc. has identified and isolated the ingredient to prevent this from happening again.

Consumers who have purchased Nopalina Flax Seed Powder and Nopalina Flax Seed Capsules having the lot numbers listed above should not consume them and are urged to return it to the place of purchase for a full refund.

Consumers with questions may contact the company at 877-296-6845 (Monday to Friday 9am-5pm) or can go to our site: https://www.nopalinaonline.com/certificate/

Symptoms of salmonellosis

Salmonella are a group of bacteria that can cause gastrointestinal illness and fever called salmonellosis. Most people infected with Salmonella begin developing symptoms 12 to 72 hours after infection. The illness usually lasts four to seven days and most people recover without treatment.

Most people with salmonellosis develop diarrhea, fever, and abdominal cramps. More severe cases of salmonellosis may include a high fever, aches, headaches, lethargy, a rash, blood in the urine or stool, and in some cases may become fatal.
Children younger than five, the elderly, and people with weakened immune systems are more likely to have severe salmonellosis infections.

Media Contact:
Michel Monfort
224-656-6223
[email protected] 

SOURCE Salud Natural Entrepreneur, Inc.


These press releases may also interest you

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....



News published on and distributed by: